Table 1.
Descriptive characteristics and body composition.
| Parameter | CTRL | HIV+ NGT | HIV+ IGT | P-value |
|---|---|---|---|---|
| N (wo/men) | 4/6 | 2/14 | 4/17 | 0.24 |
| Age (yr) | 36 ± 9 | 37 ± 9 | 43 ± 9 | 0.15 |
| HIV RNA (copies/mL) | -- | 7 ± 17 x103 | 2 ± 4 x103 | 0.12 |
| CD4 (cells/μl) | 746 ± 414 | 485 ± 146 | 579 ± 261 | 0.48 |
| Yrs known HIV+ | -- | 5.1 ± 5.1 | 8.6 ± 4.5 | 0.01 |
| Weight (kg) | 80 ± 18 | 79 ± 10 | 77 ± 13 | 0.80 |
| BMI (kg/m2) | 27 ± 4 | 26 ± 3 | 27 ± 4 | 0.51 |
| % Body Fat | 26 ± 9 | 21 ± 6 | 24 ± 9 | 0.28 |
| FFM (kg) | 58 ± 12 | 62 ± 9 | 58 ± 2 | 0.40 |
| Abdominal adipose area (cm2) | ||||
| Subcutaneous | 181 ± 102 | 155 ± 57 | 184 ± 98 | 0.65 |
| Visceral | 119 ± 96 | 117 ± 53 | 206 ± 103 | 0.05 HIV+IGT> HIV+NGT & CTRL |
| Liver Lipid Content (%) | 1.6 ± 1.1 | 1.5 ± 1.3 | 8.4 ± 9.6 | 0.02 HIV+IGT> HIV+NGT & CTRL |
Mean ± SD; CTRL= seronegative control, HIV+ NGT= HIV-infected with normal glucose tolerance, HIV+ IGT= HIV-infected with impaired glucose tolerance. P-values calculated using Kruskal-Wallis non-parametric test.